Reduced cancer-independent life expectancy in head, neck cancer

Reduced cancer-independent life expectancy in head, neck cancer

(HealthDay)—Patients with head and neck cancer have reduced life expectancy, independent of cancer, according to a study published online June 22 in Head & Neck.

Sean T. Massa, M.D., from St. Louis University, and colleagues calculated and years of life lost (YLL) for patients with head and neck cancer, referenced to the .

The researchers found that patients with head and neck cancer had cancer-independent life expectancy that was 6.5 years shorter than expected. Black race, stage IV, Medicaid, and previous marriage were associated with the greatest hazard (hazard ratios, 1.23, 1.60, 1.55, and 1.49, respectively) and impact of other-cause mortality (YLL, 8.55, 7.92, 12.9, and 11.4, respectively).

"Patients with head and lives are foreshortened independent of their cancer diagnosis necessitating management of noncancer mortality to maximize overall survival," the authors write.


Explore further

More side effects with CRT plus metformin in head, neck cancer

More information: Abstract
Full Text (subscription or payment may be required)

Copyright © 2017 HealthDay. All rights reserved.

Citation: Reduced cancer-independent life expectancy in head, neck cancer (2017, June 27) retrieved 14 December 2019 from https://medicalxpress.com/news/2017-06-cancer-independent-life-neck-cancer.html
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.
0 shares

Feedback to editors

User comments